≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Migraine, unspecified, drug-induced

EFO Endpoint Browser PheWeb

MIGRAINE_UNSPE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — G43.9#

1 out of 7 registries used, show all original rules.

260

4. Check minimum number of events

None

260

5. Include endpoints

None

260

6. Filter based on genotype QC (FinnGen only)

250

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 250 201 49
Unadjusted period prevalence (%) 0.06 0.07 0.02
Median age at first event (years) 36.65 37.29 34.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
260
Matched controls
2600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G43.9
ICD-10 Finland
Migraine, unspecified
+∞
282.5
260
106
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
13.0
100.6
156
269
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
14.8
87.5
94
96
N02CX04, ,
ATC
23.7
55.9
42
21
N02CC04
ATC
rizatriptan; oral
9.8
52.9
72
98
N02CC03
ATC
zolmitriptan; nasal, oral
9.1
49.9
72
105
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
8.1
44.8
72
118
N02CC02
ATC
naratriptan; oral
16.3
42.5
38
27
N03AX11
ATC
topiramate; oral
12.7
41.1
43
40
N02CC06
ATC
eletriptan; oral
11.3
41.0
47
50
N06CA01
ATC
amitriptyline and psycholeptics; systemic
6.3
35.8
73
151
N02CC05
ATC
almotriptan; oral
8.3
31.2
45
64
M01AG02
ATC
tolfenamic acid; oral, rectal
4.7
30.4
100
308
A03FA01
ATC
metoclopramide; systemic, rectal
3.9
25.2
109
402
R51.80
ICD-10 Finland
Headache
4.1
25.1
95
319
N02CC07
ATC
frovatriptan; oral
6.4
23.6
43
78
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
21.5
23.3
34
18
N03AG01
ATC
valproic acid; systemic, rectal
6.0
22.4
44
86
N06AA09
ATC
amitriptyline; systemic
4.6
21.0
59
157
G43
ICD-10 Finland
Migraine
5.8
20.5
41
81
N89
ICPC
Migraine
7.3
20.5
32
49
G43.3
ICD-10 Finland
Complicated migraine
17.2
20.4
32
21
G44.2
ICD-10 Finland
Tension-type headache
3.7
19.1
77
265
C07AA05
ATC
propranolol; systemic
3.3
18.8
103
430
M01AE03
ATC
ketoprofen; systemic, rectal
3.1
18.1
137
686
G43.8
ICD-10 Finland
Other migraine
14.2
16.1
27
21
3007
Kela drug reimbursment
Erenumab and fremanezumab
20.9
15.9
23
12
C08DA01
ATC
verapamil; systemic
6.2
15.4
28
50
C07AB02
ATC
metoprolol; systemic
3.3
14.4
66
242
N05BA01
ATC
diazepam; systemic, rectal
3.4
14.3
61
214
C07AB07
ATC
bisoprolol; oral
2.7
13.9
138
768
N02AX02
ATC
tramadol; systemic, rectal
2.7
13.6
141
799
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.2
13.5
40
109
R07.4
ICD-10 Finland
Chest pain, unspecified
2.8
13.2
96
455
N02CD01
ATC
erenumab; parenteral
25.8
12.6
17
7
N05AB04
ATC
prochlorperazine; systemic, rectal
11.9
12.3
22
20
AA1AD
NOMESCO Finland
CT of head and brain
2.7
11.7
83
384
N03AX12
ATC
[U] gabapentin; oral
2.9
11.6
69
291
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
11.5
126
718
C09CA06
ATC
candesartan; oral
2.6
11.2
84
399
R518, ,
ICD-10 Finland
45.4
11.0
13
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
10.6
47
167
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
10.6
91
460
A02BA02
ATC
ranitidine; systemic
2.7
10.5
67
293
A02BC01
ATC
omeprazole; systemic
2.5
10.2
88
444
H02AB07
ATC
prednisone; oral
3.0
10.2
50
189
J01MA02
ATC
ciprofloxacin; systemic
2.4
10.2
113
639
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
41.8
10.0
12
*
A02BC02
ATC
pantoprazole; systemic
2.6
10.0
198
1432
N06AX16
ATC
venlafaxine; oral
2.7
10.0
66
293
N02CD03
ATC
fremanezumab; systemic
21.0
9.9
14
7
M03BC51
ATC
orphenadrine, combinations; systemic
2.3
9.7
104
577
N06AX11
ATC
mirtazapine; oral
2.3
9.5
116
677
N03AX16
ATC
[U] pregabalin
2.4
9.5
83
419
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
9.4
67
307
M01AB01
ATC
indometacin; systemic, rectal
4.6
9.3
23
54
H02AB06
ATC
prednisolone; systemic
2.2
9.3
140
891
H02AB04
ATC
methylprednisolone; systemic
2.8
9.1
53
219
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
9.1
52
213
N06AX21
ATC
duloxetine; oral
2.8
9.0
53
220
M01AE02
ATC
naproxen; oral, rectal
2.3
8.7
179
1276
R20.2
ICD-10 Finland
Paraesthesia of skin
3.3
8.6
34
112
G43.2
ICD-10 Finland
Status migrainosus
34.5
8.1
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
8.0
114
697
N06AB04
ATC
citalopram; systemic
2.3
7.8
75
391
N02CA01
ATC
dihydroergotamine; nasal, systemic
46.4
7.8
9
*
ZXE00
NOMESCO Finland
One hour or less
2.1
7.7
119
749
R51
ICD-10 Finland
Headache
3.5
7.6
27
83
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.7
7.6
25
73
R11
ICD-10 Finland
Nausea and vomiting
3.1
7.5
33
116
N03AX09
ATC
lamotrigine; oral
3.5
7.5
26
79
M03AX01
ATC
botulinum toxin; parenteral
12.5
7.2
12
10
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
7.1
138
936
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
7.0
47
208
M03BX02
ATC
tizanidine; oral
2.2
6.9
194
1494
J02AC01
ATC
fluconazole; systemic
2.0
6.9
140
959
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
6.9
39
158
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
6.9
63
320
N05CD07
ATC
temazepam; oral
2.9
6.9
35
134
G44.0
ICD-10 Finland
Cluster headache syndrome
9.7
6.9
13
14
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
6.7
53
252
A02BC05
ATC
esomeprazole; systemic
2.0
6.7
123
812
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
6.6
65
340
M79.6
ICD-10 Finland
Pain in limb
1.9
6.5
127
855
N02AC04
ATC
dextropropoxyphene; oral
6.0
6.3
16
28
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
6.2
80
463
J01DA01
ATC
[U] cefalexin
2.0
6.2
181
1384
Z2221
NOMESCO Finland
Medical doctor
2.0
6.1
85
507
N02BF02
ATC
pregabalin; oral
3.0
6.0
27
96
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
6.0
81
476

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
76
357
2.60
10.26
3.4
3.3
27.40
138.61
ng/l
1.51
60
248
193
1507
2.09
6.30
3.7
3.3
—
—
—
0
0
58
297
2.23
6.19
1.3
1.2
—
—
—
0
0
126
855
1.92
6.19
5.2
4.2
36.67
36.52
g/l
0.12
121
807
78
449
2.05
6.16
1.4
1.3
30.59
26.01
iu/ml
0.13
25
158
62
330
2.15
6.00
1.4
1.4
390.00
489.88
titre
0.34
12
81
72
412
2.03
5.74
2.6
2.5
6.85
7.67
e6/l
0.11
62
380
36
154
2.55
5.71
1.2
1.2
—
—
—
0
0
206
1688
2.06
5.34
4.9
3.9
9.76
10.22
mm/h
0.29
195
1557
157
1186
1.82
5.14
4.4
4.7
6.10
6.47
mmol/l
1.94
147
1090
77
479
1.86
4.70
2.4
2.0
3.32
2.93
mg/l
0.67
61
407
91
601
1.79
4.56
3.7
3.0
27.93
36.12
e6/l
0.20
74
450
174
1382
1.78
4.54
5.2
4.2
540.80
185.30
e6/l
—
5
23
86
559
1.80
4.54
1.2
1.2
0.67
1.10
u/ml
1.31
20
166
228
1980
2.23
4.48
18.9
14.6
14.11
14.59
%
0.83
223
1955
73
461
1.81
4.20
3.7
3.7
1.01
1.02
kg/l
—
9
55
63
383
1.85
4.08
2.0
2.5
546.26
530.01
mosm/kgh2o
0.20
54
329
200
1681
1.82
4.03
7.3
7.1
72.07
75.76
u/l
0.90
189
1577
110
789
1.68
4.00
2.0
1.8
95.37
98.93
pmol/l
0.35
56
374
144
1109
1.67
3.98
6.0
5.5
1.93
1.99
e9/l
0.23
132
997
92
632
1.71
3.91
4.1
3.8
7.40
7.40
ph
0.03
18
109
82
550
1.72
3.79
3.3
2.8
0.23
0.42
e6/l
1.01
66
396
53
314
1.86
3.70
1.7
1.6
1125.21
1232.01
nmol/l
0.43
42
235
75
496
1.72
3.63
1.3
1.4
2.16
2.40
g/l
0.57
38
301
61
382
1.78
3.56
1.5
1.7
352.67
15528411.81
pmol/l
0.50
49
322
144
1131
1.61
3.51
5.2
5.9
10.06
10.00
umol/l
0.04
138
1072
68
442
1.73
3.48
1.3
1.3
1.33
11.02
u/ml
3.11
22
173
70
460
1.71
3.45
4.4
4.1
—
—
—
0
0
88
615
1.65
3.44
2.0
2.1
125.92
150.33
u/l
0.46
83
583
59
370
1.77
3.42
2.2
2.5
2.43
2.44
mmol/l
0.21
47
331
44
252
1.90
3.40
3.5
2.3
4.62
6.36
umol/l
1.40
39
215
74
496
1.69
3.38
2.0
1.7
1.49
0.81
mg/l
0.68
56
382
80
553
1.65
3.24
3.4
2.7
—
—
—
0
0
205
1778
1.72
3.20
4.5
4.2
14.08
14.56
pmol/l
2.23
192
1647
26
126
2.18
3.15
1.2
1.2
—
—
—
0
0
177
1483
1.61
3.13
4.7
3.9
—
—
—
0
0
22
100
2.31
3.09
1.0
1.1
—
—
—
0
0
48
295
1.77
2.96
2.8
2.7
2.40
3.36
e6/l
0.40
25
134
131
1034
1.54
2.95
3.0
2.7
84.57
93.92
ug/l
0.41
122
962
111
849
1.54
2.86
12.9
9.8
1.15
1.14
inr
0.08
36
250
135
1078
1.52
2.84
6.1
5.5
0.53
0.54
e9/l
0.44
118
948
130
1030
1.52
2.84
5.7
6.0
—
—
—
0
0
243
2243
2.28
2.84
16.8
11.8
18.31
20.75
mg/l
0.65
205
1695
116
899
1.52
2.80
5.6
5.9
1.22
1.22
mmol/l
0.30
108
828
124
975
1.52
2.79
8.7
8.5
0.00
0.00
e9/l
0.95
101
793
135
1081
1.52
2.79
6.1
5.5
0.04
0.04
e9/l
0.16
118
950
96
716
1.54
2.75
3.4
3.2
17.93
22.54
ng/l
0.37
53
428
124
980
1.51
2.70
6.4
6.6
1.22
1.22
mmol/l
0.07
104
837
97
729
1.53
2.67
4.4
3.5
92.37
57.58
e6/l
0.31
76
486
94
704
1.53
2.62
2.1
3.3
2.36
2.36
mmol/l
0.04
82
629
230
2094
1.85
2.62
5.4
4.9
1.92
2.38
mu/l
0.38
214
1955
128
1025
1.49
2.58
6.4
5.5
57.59
56.66
%
0.39
119
969
153
1273
1.49
2.53
7.1
9.4
4.14
3.93
e9/l
0.53
133
1122
138
1125
1.48
2.53
6.3
5.8
0.18
0.18
e9/l
0.15
129
1001
38
230
1.76
2.47
1.9
1.5
—
—
—
0
0
131
1066
1.46
2.37
3.9
3.4
0.00
0.00
estimate
-0.00
22
222
128
1037
1.46
2.37
6.6
5.6
29.24
28.90
%
0.14
120
984
81
601
1.51
2.32
2.0
1.6
1.39
1.39
mmol/l
0.00
67
519
82
610
1.50
2.32
3.4
2.6
—
—
—
0
0
13
53
2.53
2.31
3.6
2.6
—
—
—
0
0
131
1070
1.45
2.30
4.9
4.5
0.00
0.00
estimate
-0.00
23
211
132
1083
1.44
2.25
3.9
3.4
0.00
0.00
estimate
-0.00
22
200
7
19
3.76
2.16
1.7
1.2
—
—
—
0
0
32
193
1.75
2.12
1.1
1.2
—
—
—
0
0
107
858
1.42
2.01
3.4
3.2
6.64
5.85
ph
—
7
72
66
483
1.49
2.00
3.7
3.4
—
—
—
0
0
118
968
1.40
1.93
6.6
5.6
0.65
0.72
%
0.57
110
903
21
117
1.86
1.80
2.3
2.8
—
—
—
0
0
230
2143
1.63
1.77
4.2
4.1
5.65
5.79
mmol/l
1.06
213
1994
69
523
1.43
1.73
1.7
2.6
299.69
6270.75
umol/l
2.51
54
468
31
197
1.65
1.72
1.2
1.2
176.13
172.89
iu/ml
0.01
11
85
5
13
3.90
1.72
1.4
1.4
1.82
1.89
mmol/l
—
5
13
40
272
1.56
1.70
2.2
2.2
2.33
2.45
g/l
0.73
33
254
120
1008
1.35
1.62
7.1
5.9
8.11
8.36
%
0.51
112
952
8
32
2.55
1.61
1.3
1.1
—
—
—
0
0
7
26
2.74
1.59
1.7
2.8
—
—
—
0
0
12
57
2.16
1.57
1.6
2.1
—
—
—
0
0
119
1002
1.35
1.57
6.8
5.6
2.81
2.81
%
0.02
111
943
43
309
1.47
1.42
2.1
2.1
151.94
106.28
ug/g
0.44
33
244
9
42
2.18
1.35
1.4
1.8
—
—
—
0
0
16
91
1.81
1.32
12.0
14.5
—
—
—
0
0
16
91
1.81
1.32
1.6
1.5
—
—
—
0
0
59
457
1.38
1.30
1.5
1.5
21.97
22.42
nmol/l
0.08
50
385
217
2029
1.42
1.29
5.0
5.0
37.97
38.91
mmol/mol
0.81
204
1910
11
55
2.04
1.29
1.3
1.2
3.92
3.73
mmol/l
0.35
11
49
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
10
49
2.08
1.23
1.5
1.3
—
—
—
0
0
10
49
2.08
1.23
3.6
2.0
104.15
153.73
ug/l
—
10
43
5
19
2.66
1.22
1.0
3.7
—
—
—
0
0
15
86
1.79
1.22
1.7
1.5
—
—
—
0
0
35
250
1.46
1.21
1.3
1.3
—
—
—
0
0
6
26
2.34
1.19
1.0
1.3
—
—
—
0
0
13
73
1.82
1.13
1.2
1.2
—
—
—
0
0
7
32
2.22
1.09
1.7
3.3
—
—
—
0
0
38
282
1.41
1.08
3.0
2.2
—
—
—
0
0
244
2351
1.62
1.05
15.3
11.0
—
—
—
0
0
23
156
1.52
1.02
1.3
1.4
—
—
—
0
0
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
9
51
1.79
0.95
1.1
1.2
—
—
—
0
0
68
565
1.28
0.93
5.6
7.0
—
—
—
0
0
6
28
2.17
0.92
1.3
1.4
—
—
—
0
0
11
63
1.78
0.91
1.0
1.8
—
—
—
0
0
6
29
2.09
0.90
1.3
1.3
—
—
—
0
0
13
79
1.68
0.90
1.6
2.1
17.86
4348.00
u/l
—
5
27
6
31
1.96
0.85
1.5
1.3
—
—
—
0
0
10
57
1.78
0.85
1.1
1.1
—
—
—
0
0
22
155
1.46
0.84
2.7
3.2
—
—
—
0
0
12
188
0.62
0.83
1.3
1.4
—
—
—
0
0
25
182
1.41
0.81
4.2
3.5
—
—
—
0
0
8
47
1.72
0.81
1.9
1.6
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
1.74
—
0
8
12
75
1.63
0.76
1.7
1.5
—
—
—
0
0
24
176
1.40
0.76
8.1
10.4
96.40
96.04
%
0.18
24
171
7
38
1.86
0.74
2.7
1.7
—
—
—
0
0
27
204
1.36
0.72
6.6
6.6
103.63
104.18
mmol/l
0.18
27
204
67
574
1.23
0.70
4.8
3.8
0.00
0.00
estimate
0.50
22
208
21
153
1.41
0.69
1.3
1.4
—
—
—
0
0
15
104
1.47
0.64
2.1
2.3
—
—
—
0
0
32
254
1.30
0.63
1.5
1.5
—
—
—
0
0
70
610
1.20
0.62
3.5
2.9
—
—
—
0
0
104
940
1.18
0.61
2.2
2.0
—
—
—
0
0
0
22
0.00
0.59
0.0
3.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
12
172
0.68
0.58
2.9
3.9
—
—
—
0
0
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
17
125
1.39
0.55
1.1
1.1
—
—
—
0
0
82
912
0.85
0.55
2.7
2.7
—
—
—
0
0
6
38
1.59
0.54
2.3
3.1
26.47
24.45
mmol/l
—
6
38
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
254
2504
1.62
0.53
23.4
17.7
39.96
40.47
%
0.64
239
2373
18
135
1.36
0.52
3.2
2.0
8.02
4.23
ug/l
0.51
18
119
16
118
1.38
0.51
1.1
1.1
—
—
—
0
0
10
68
1.49
0.47
2.1
3.2
—
—
—
0
0
67
597
1.16
0.46
2.6
2.9
7.93
7.29
mmol/l
0.51
55
507
32
267
1.23
0.45
1.5
1.4
—
—
—
0
0
6
91
0.65
0.43
4.2
2.5
—
—
—
0
0
254
2507
1.57
0.43
23.4
17.8
135.43
135.24
g/l
0.08
254
2474
254
2505
1.61
0.43
23.2
17.6
30.10
30.23
pg
0.68
254
2473
254
2505
1.61
0.43
23.2
17.7
90.32
90.84
fl
1.15
254
2473
10
70
1.45
0.42
1.1
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
2.6
—
105.53
—
0
19
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
0
19
0.00
0.39
0.0
2.6
—
3.99
—
0
19
11
80
1.39
0.39
7.9
6.1
—
—
—
0
0
32
273
1.20
0.37
2.0
1.4
—
—
—
0
0
5
37
1.36
0.37
1.8
1.7
—
—
—
0
0
25
298
0.82
0.37
1.2
1.3
—
—
—
0
0
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
6
44
1.37
0.34
1.8
1.6
33.50
36.20
nmol/l
—
6
44
57
628
0.88
0.33
1.6
1.5
—
—
—
0
0
49
440
1.14
0.31
1.8
1.8
—
—
—
0
0
109
1030
1.10
0.29
2.7
2.4
—
—
—
0
0
231
2269
1.16
0.28
4.9
4.6
2.94
2.89
mmol/l
0.35
214
2121
228
2238
1.15
0.27
4.3
4.2
4.86
4.86
mmol/l
0.02
217
2103
25
285
0.86
0.24
1.4
1.2
—
—
—
0
0
5
39
1.29
0.23
1.4
2.0
—
—
—
0
0
5
40
1.25
0.22
2.8
3.1
3.57
4.80
e9/l
—
5
40
19
163
1.18
0.22
2.2
2.5
0.65
0.73
ug/l
—
10
91
5
41
1.22
0.22
2.8
3.6
60.00
58.51
%
—
5
41
0
11
0.00
0.21
0.0
2.1
—
725.60
—
0
5
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
536.00
—
0
5
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
35.19
—
0
12
226
2225
1.12
0.21
4.3
4.1
1.49
1.54
mmol/l
1.01
213
2082
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
188.99
—
0
13
57
531
1.09
0.20
2.7
3.1
1164.66
309.36
mg/l
0.34
38
319
16
136
1.19
0.20
11.4
8.0
—
—
—
0
0
18
155
1.17
0.20
6.9
3.4
—
—
—
0
0
58
543
1.09
0.19
3.2
3.2
—
—
—
0
0
7
58
1.21
0.18
2.1
3.4
23.99
24.79
mmol/l
—
7
58
17
148
1.16
0.17
7.3
3.2
1.85
2.32
mmol/l
0.30
17
119
28
254
1.11
0.16
1.9
1.8
—
—
—
0
0
39
361
1.09
0.16
1.5
1.6
—
—
—
0
0
11
92
1.20
0.16
1.1
1.2
—
—
—
0
0
9
80
1.13
0.15
1.8
1.6
—
—
—
0
0
9
81
1.12
0.15
4.2
2.3
0.54
0.65
%
—
9
81
59
559
1.07
0.15
3.3
3.7
7.58
8.18
mg/mmol
0.04
34
320
10
84
1.20
0.14
8.3
2.3
1.17
1.28
%
—
10
84
13
113
1.16
0.13
8.5
8.8
—
—
—
0
0
16
142
1.14
0.13
2.6
2.8
72.02
75.13
e9/l
—
10
105
19
209
0.90
0.11
2.4
3.8
2.26
8.68
ug/l
1.88
11
170
18
198
0.90
0.11
1.2
1.3
—
—
—
0
0
5
47
1.07
0.09
1.2
2.5
7.43
7.43
ph
—
5
40
11
123
0.89
0.08
16.0
7.7
9.17
8.27
mmol/l
0.22
11
116
6
70
0.85
0.07
6.5
4.3
—
—
—
0
0
9
101
0.89
0.06
3.1
1.8
—
—
—
0
0
25
238
1.06
0.05
1.4
1.7
—
—
—
0
0
68
665
1.03
0.05
2.7
2.1
—
—
—
0
0
15
140
1.08
0.04
3.8
2.5
—
—
—
0
0
213
2143
0.97
0.04
3.8
3.8
1.30
1.28
mmol/l
0.18
195
1993
11
102
1.08
0.03
6.4
5.5
24.30
25.15
mmol/l
0.44
11
102
17
163
1.05
0.01
1.4
1.9
—
—
—
0
0
22
226
0.97
0.00
1.6
1.4
—
—
—
0
0
18
183
0.98
0.00
4.1
2.4
0.20
0.23
g/l
0.77
18
173
0
5
0.00
0.00
0.0
1.0
—
0.05
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
1.61
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.20
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
7.75
—
0
8
5
51
0.98
-0.00
1.4
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
155.63
—
0
9
0
6
0.00
-0.00
0.0
2.7
—
10.71
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: MIGRAINE_UNSPE – Migraine, unspecified, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).